EAST WINDSOR--A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication and under development for adult patients with moderate-to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial medication every other week for up to 52 weeks. For all trial participants, the trial will include up o 31 visits to the trial clinic. Atopic dermatitis (AD) is a chronic inflammatory skin disease. In its severe form, AD is characterised by widespread skin lesions, itch, as well as increased risk of skin infection. AD is associated with a substantial burden that typically includes poor quality of life, sleep disturbance, and reductions in work productivity. There is no cost to participate in this clinical study and reasonable travel expenses will be reimbursed.
To find out more about this study and how to get involved please contact:
Ashley Varga at Windsor Dermatology on 609-443-0424